Detalhe da pesquisa
1.
Implementing MyChoice® CDx HRD testing for the Nordics: lessons from 2021 to 2023.
Acta Oncol
; 63: 70-75, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38482597
2.
Management of endometrial cancer in Latin America: raising the standard of care and optimizing outcomes.
Int J Gynecol Cancer
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697755
3.
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design.
Int J Gynecol Cancer
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627035
4.
Patient care and access to clinical trials in gynaecological oncology: global implications of the early phase of the COVID-19 pandemic.
Arch Gynecol Obstet
; 310(1): 577-586, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38836928
5.
Advances in the Management of Recurrent Cervical Cancer: State of the Art and Future Perspectives.
Curr Oncol Rep
; 25(11): 1307-1326, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870697
6.
Evolving treatment paradigms in metastatic or recurrent low-grade endometrial cancer: When is hormonal-based therapy the preferred option?
Int J Gynecol Cancer
; 33(11): 1675-1681, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37640446
7.
The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinoma.
Int J Gynecol Cancer
; 33(12): 1943-1949, 2023 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37907262
8.
European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023.
Int J Gynecol Cancer
; 33(7): 1023-1043, 2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369376
9.
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Lancet Oncol
; 23(8): e374-e384, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35901833
10.
Comparison of global treatment guidelines for locally advanced cervical cancer to optimize best care practices: A systematic and scoping review.
Gynecol Oncol
; 167(2): 360-372, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096973
11.
Impact of disease progression on health-related quality of life of advanced ovarian cancer patients - Pooled analysis from the PRIMA trial.
Gynecol Oncol
; 166(3): 494-502, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35851489
12.
Patient perspectives and experiences of the rapid implementation of digital consultations during COVID-19 - a qualitative study among women with gynecological cancer.
Support Care Cancer
; 30(3): 2545-2554, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34796401
13.
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
Int J Gynecol Cancer
; 31(1): 12-39, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33397713
14.
Results of the interprofessional and interdisciplinary Berlin round table on patient-reported outcomes, quality of life, and treatment expectations of patients with gynecological cancer under maintenance treatment.
Int J Gynecol Cancer
; 30(10): 1603-1607, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32817309
15.
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
Lancet Oncol
; 20(10): 1409-1419, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31474354
16.
Clinical pathways of recovery after surgery for advanced ovarian/tubal/peritoneal cancer: an NSGO-MaNGO international survey in collaboration with AGO-a focus on surgical aspects.
Int J Gynecol Cancer
; 29(1): 181-187, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30640702
17.
Patterns of treatment failure in patients undergoing adjuvant or definitive radiotherapy for vulvar cancer.
Int J Gynecol Cancer
; 2019 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31126968
18.
The poly (ADP ribose) polymerase inhibitor niraparib: Management of toxicities.
Gynecol Oncol
; 149(1): 214-220, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29397193
19.
Overall survival after PARP maintenance treatment in platinum-sensitive relapsed ovarian cancer: opposing views of the US Food and Drug Administration and European Medicines Agency.
Int J Gynecol Cancer
; 33(6): 1008-1009, 2023 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37024238
20.
Highlights from the 24th European Congress on Gynaecological Oncology in Istanbul: an ENYGO-IJGC Fellows compilation.
Int J Gynecol Cancer
; 2023 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38114163